Notice Number: NOT-AI-19-075

Key Dates
Release Date: October 1, 2019

Issued by
National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

The purpose of this Notice is to announce the participation of the National Institute of Allergy and Infectious Diseases (NIAID) in NOT-DE-19-013 "Clarifications Regarding Institutional Eligibility for PAR-19-134 "Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)".

The following section has been updated to reflect the participation of NIAID in this Notice.

Issued by

Currently Reads:

National Institute of Dental and Craniofacial Research (NIDCR)
National Institute on Aging (NIA)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute on Drug Abuse (NIDA)
National Institute of Environmental Health Sciences (NIEHS)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute of Nursing Research (NINR)
National Center for Complementary and Integrative Health (NCCIH)
National Cancer Institute (NCI)

Modified to Read:

National Institute of Dental and Craniofacial Research (NIDCR)
National Institute on Aging (NIA )
National Institute on Alcohol Abuse and Alcoholism (NIAAA )
National Institute of Allergy and Infectious Diseases (NIAID )
National Institute on Deafness and Other Communication Disorders (NIDCD )
National Institute on Drug Abuse (NIDA )
National Institute of Environmental Health Sciences (NIEHS )
National Institute of Neurological Disorders and Stroke (NINDS )
National Institute of Nursing Research (NINR )
National Center for Complementary and Integrative Health (NCCIH )
National Cancer Institute (NCI )

All other aspects of this Notice remain the same.

Inquiries

Please direct all inquiries to:

Diane Adger-Johnson, MPH
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-669-2924
Email: AITrainingHelpDesk@niaid.nih.gov